drugset / Trial / NCT00612313

Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse

NCT00612313

RandomizedParallel-groupSingle-blindTreatment

Summary

This study will compare the effectiveness of fluoxetine alone with the effectiveness of fluoxetine with cognitive behavioral therapy in increasing recovery and preventing relapse in youth with major depressive disorder.

Timeline

Start
2008-02
Primary completion
2013-02
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule 10 mg
Subject Fluoxetine Small molecule 40 mg

Indications